ENTRY       D09631                      Drug
NAME        Intetumumab (USAN/INN)
FORMULA     C6468H10008N1744O2006S40
EXACT_MASS  145488.3555
MOL_WEIGHT  145577.7523
SEQUENCE    (Heavy chain)
            QVQLVESGGG VVQPGRSRRL SCAASGFTFS RYTMHWVRQA PGKGLEWVAV ISFDGSNKYY
            VDSVKGRFTI SRDNSENTLY LQVNILRAED TAVYYCAREA RGSYAFDIWG QGTMVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD ASNRATGIPA
            RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPPFTFG PGTKVDIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H146-H202, H263-H323, H369-H427, H228-H'228, H231-H'231, L23-L88, L135-L195, H222-L215)
  TYPE      Peptide
EFFICACY    Antineoplastic, Angiogenesis inhibitor
  TYPE      Monoclonal antibody
COMMENT     Treatment of solid tumors
TARGET      ITGAV (CD51) [HSA:3685] [KO:K06487]
  PATHWAY   hsa04510(3685)  Focal adhesion
            hsa04512(3685)  ECM-receptor interaction
            hsa04514(3685)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: other families
               Integrins
                ITGAV (CD51)
                 D09631  Intetumumab (USAN/INN)
DBLINKS     CAS: 725735-28-4
            PubChem: 124490371
///
